- Home
- OESX vs PMN Comparison
OESX vs PMN Comparison
Compare OESX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OESX
- PMN
- Stock Information
- Founded
- OESX 1996
- PMN 2004
- Country
- OESX United States
- PMN Canada
- Employees
- OESX N/A
- PMN N/A
- Industry
- OESX Building Products
- PMN Pharmaceuticals and Biotechnology
- Sector
- OESX Consumer Discretionary
- PMN Health Care
- Exchange
- OESX Nasdaq
- PMN Nasdaq
- Market Cap
- OESX 27.5M
- PMN 32.3M
- IPO Year
- OESX 2007
- PMN N/A
- Fundamental
- Price
- OESX $0.82
- PMN $1.03
- Analyst Decision
- OESX Strong Buy
- PMN
- Analyst Count
- OESX 1
- PMN 0
- Target Price
- OESX $3.00
- PMN N/A
- AVG Volume (30 Days)
- OESX 72.0K
- PMN 88.6K
- Earning Date
- OESX 11-06-2024
- PMN 12-03-2024
- Dividend Yield
- OESX N/A
- PMN N/A
- EPS Growth
- OESX N/A
- PMN N/A
- EPS
- OESX N/A
- PMN N/A
- Revenue
- OESX $91,649,000.00
- PMN N/A
- Revenue This Year
- OESX $13.74
- PMN N/A
- Revenue Next Year
- OESX $14.83
- PMN N/A
- P/E Ratio
- OESX N/A
- PMN N/A
- Revenue Growth
- OESX 14.40
- PMN N/A
- 52 Week Low
- OESX $0.81
- PMN $0.91
- 52 Week High
- OESX $1.53
- PMN $3.10
- Technical
- Relative Strength Index (RSI)
- OESX 33.60
- PMN 49.37
- Support Level
- OESX $0.92
- PMN $0.91
- Resistance Level
- OESX $0.94
- PMN $1.08
- Average True Range (ATR)
- OESX 0.05
- PMN 0.07
- MACD
- OESX -0.02
- PMN 0.00
- Stochastic Oscillator
- OESX 0.10
- PMN 62.89
About OESX Orion Energy Systems Inc.
Orion Energy Systems Inc is a developer, manufacturer, and seller of lighting and energy management systems. The company segments include Orion Lighting Segment, Orion Maintenance Segment and Orion Electric Vehicle Charging Segment. It derives maximum revenue from Lighting Segment.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.